Mineralys Therapeutics (MLYS) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

MLYS is expected to report earnings to fall 37.17% to -70 cents per share on March 12

Mineralys Therapeutics MLYS Stock Earnings Reports

Q4'24

Est.

$-0.71

Q3'24

Missed

by $0.42

Q2'24

Missed

by $0.11

Q1'24

Beat

by $0.02

Q4'23

Beat

by $0.22

The last earnings report on November 11 showed earnings per share of -112 cents, missing the estimate of -70 cents. With 96.31K shares outstanding, the current market capitalization sits at 613.65M.

View a ticker or compare two or three

Compare

MLYS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MLYS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for MLYS (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

150 North Radnor Chester Road

Phone

+1 888 378-6240

Employees

Web

https://mineralystx.com